FACTS ABOUT MODAFINIL NORGE REVEALED

Stone et al (2002) showed the α1A adrenergic receptor antagonist WB4101 plus the α1D antagonist BMY7378 had minor effect on the increase in motor exercise attributable to modafinil, but terazosin, which blocks α1A, α1D, and α1B receptors considerably attenuated this impact. On top of that, modafinil had pretty compact effects on gross movement